The rapid rise in prescriptions for GLP-1 weight loss drugs had a muted effect on Delaware health insurers’ spending thanks ...

CVS Caremark is facing a lawsuit after being accused of pointing patients to use a weight loss drug called Wegovy and for ...

“Obesity is a complex disease,” says Shauna Levy, medical director of the Tulane School of Medicine’s Bariatric and Weight Loss Center. “The fact is that not everyone responds to the same treatments, ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s ...

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. | A new ...

A class-action lawsuit filed against CVS Caremark argues that the PBM dropping coverage of Zepbound for Wegovy is illegal.

Eli Lilly and Company ( NYSE: LLY) 2025 Wells Fargo Healthcare Conference September 5, 2025 9:30 AM EDT ...

Two New York residents have filed a lawsuit against CVS after the company’s pharmacy benefit manager, Caremark, denied coverage for Zepbound in favor of Wegovy. The plaintiffs — Dennis Larkin of ...